MEDICAL DEVICE INNOVATION - Medical Device Daily

MEDICAL DEVICE INNOVATION 2010
147
she said. Or, for another way of looking at it, she said it
would be like “kicking the pop machine.”
“If you don’t monitor the eyes and understand eye patterns
you’re kicking the pop machine and hoping that what
you’re doing works,” Epley said. “It’s wasting the level of
science in our field, which is an undeveloped area compared
to something like cardiology.” With the Omniax system,
a physician can now rule in or rule out various causes
of vestibular vertigo and if it is determined that the cause is
particles in the ear canal, the system provides a means to
more easily and more effectively treat it, according to
Vesticon. Research for the company’s products currently in
development has been “generously” supported by the
National Institutes of Health Small Business Innovation
Program, Vesticon noted. The Omniax was the first of the
company’s products to gain FDA approval.
“Previously, much of our energy went into holding the
patient in place and safely maneuvering the patient, which
can be quite difficult when the individual is frail or heavy or
experiencing nausea,” Hansen said. “With the Omniax, my
patients are securely held in the exact position required
and I can concentrate on watching the eye movements.”
(This story originally appeared in the July 22, 2009, edition
of Medical Device Daily).
To subscribe, please call MEDICAL DEVICE DAILY Customer Service at (800) 888-3912; outside the U.S. and Canada, call (404) 262-5547.
Copyright © 2010 AHC Media LLC. Reproduction is strictly prohibited.